The latest closing stock price for Aquestive Therapeutics as of November 22, 2024 is 4.56.
An investor who bought $1,000 worth of Aquestive Therapeutics stock at the IPO in 2018 would have $-716 today, roughly -1 times their original investment - a -18.92% compound annual growth rate over 6 years.
The all-time high Aquestive Therapeutics stock closing price was 18.96 on September 07, 2018.
The Aquestive Therapeutics 52-week high stock price is 6.23, which is 36.6% above the current share price.
The Aquestive Therapeutics 52-week low stock price is 1.84, which is 59.6% below the current share price.
The average Aquestive Therapeutics stock price for the last 52 weeks is 3.61.
An investor who bought $1,000 worth of Aquestive Therapeutics stock at the IPO in 2018 would have $-716 today, roughly -1 times their original investment - a -18.92% compound annual growth rate over 6 years.
The all-time high Aquestive Therapeutics stock closing price was 18.96 on September 07, 2018.
The Aquestive Therapeutics 52-week high stock price is 6.23, which is 36.6% above the current share price.
The Aquestive Therapeutics 52-week low stock price is 1.84, which is 59.6% below the current share price.
The average Aquestive Therapeutics stock price for the last 52 weeks is 3.61.